Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: May 16, 2016

Total Value ($000): $453,821 (99.9% shares, 0.1% debt)

Holdings (16)

ABBV ABBVIE INC. 19.9%

Value ($000) $90,249 Shares 1,580,000 Est. Cost $38.85 Unrealized -4.5%

— ARIAD PHARMACEUTICALS INC 18.1%

Value ($000) $82,111 Shares 12,850,000 Est. Cost $6.73 Unrealized —

BIIB BIOGEN INC 17.8%

Value ($000) $80,699 Shares 310,000 Est. Cost $287.35 Unrealized -8.1%

— MEDICINES CO 12.3%

Value ($000) $55,661 Shares 1,752,000 Est. Cost $29.63 Unrealized —

DGX QUEST DIAGNOSTICS INC 9.1%

Value ($000) $41,083 Shares 575,000 Est. Cost $46.05 Unrealized +19.8%

PCRX PACIRA PHARMACEUTICALS INC 6.2%

Value ($000) $28,195 Shares 532,200 Est. Cost $59.93 Unrealized -2.4%

— INTRA CELLULAR THERAPIES INC 4.1%

Value ($000) $18,764 Shares 675,000 Est. Cost $27.96 Unrealized —

— RAPTOR PHARMACEUTICAL CORP 2.8%

Value ($000) $12,535 Shares 2,725,000 Est. Cost $4.60 Unrealized —

ESPR ESPERION THERAPEUTICS INC NE 2.4%

Value ($000) $10,704 Shares 633,000 Est. Cost $49.12 Unrealized -67.2%

— AEGERION PHARMACEUTICALS INC 2.1%

Value ($000) $9,546 Shares 2,580,000 Est. Cost $22.50 Unrealized —

— ARRAY BIOPHARMA INC 1.9%

Value ($000) $8,481 Shares 2,875,000 Est. Cost $3.26 Unrealized —

— APRICUS BIOSCIENCES INC 1.9%

Value ($000) $8,412 Shares 14,479,052 Est. Cost $1.10 Unrealized —

— VIVUS INC 0.8%

Value ($000) $3,603 Shares 2,573,943 Est. Cost $9.08 Unrealized —

— AVEO PHARMACEUTICALS INC 0.5%

Value ($000) $2,128 Shares 2,313,759 Est. Cost $1.84 Unrealized —

— REPROS THERAPEUTICS INC 0.2%

Value ($000) $970 Shares 1,001,000 Est. Cost $16.90 Unrealized —

— TARGACEPT INC 0.1%

Value ($000) $680 Shares 680,399 Est. Cost $1.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ABBV	ABBVIE INC.	1,580,000	$90,249	19.9%	$38.85	-4.5%	COM	00287Y109
—	ARIAD PHARMACEUTICALS INC	12,850,000	$82,111	18.1%	$6.73	—	COM	04033A100
BIIB	BIOGEN INC	310,000	$80,699	17.8%	$287.35	-8.1%	COM	09062X103
—	MEDICINES CO	1,752,000	$55,661	12.3%	$29.63	—	COM	584688105
DGX	QUEST DIAGNOSTICS INC	575,000	$41,083	9.1%	$46.05	+19.8%	COM	74834L100
PCRX	PACIRA PHARMACEUTICALS INC	532,200	$28,195	6.2%	$59.93	-2.4%	COM	695127100
—	INTRA CELLULAR THERAPIES INC	675,000	$18,764	4.1%	$27.96	—	COM	46116X101
—	RAPTOR PHARMACEUTICAL CORP	2,725,000	$12,535	2.8%	$4.60	—	COM	75382F106
ESPR	ESPERION THERAPEUTICS INC NE	633,000	$10,704	2.4%	$49.12	-67.2%	COM	29664W105
—	AEGERION PHARMACEUTICALS INC	2,580,000	$9,546	2.1%	$22.50	—	COM	00767E102
—	ARRAY BIOPHARMA INC	2,875,000	$8,481	1.9%	$3.26	—	COM	04269X105
—	APRICUS BIOSCIENCES INC	14,479,052	$8,412	1.9%	$1.10	—	COM	03832V109
—	VIVUS INC	2,573,943	$3,603	0.8%	$9.08	—	COM	928551100
—	AVEO PHARMACEUTICALS INC	2,313,759	$2,128	0.5%	$1.84	—	COM	053588109
—	REPROS THERAPEUTICS INC	1,001,000	$970	0.2%	$16.90	—	COM NEW	76028H209
—	TARGACEPT INC	680,399	$680	0.1%	$1.00	—	NOTE 2/1	87611RAA6